SynthesisApplied health economics and health policy2023
The Impact of Value-Based Payment Models for Networks of Care and Transmural Care: A Systematic Literature Review.
Synthesis in Applied health economics and health policy, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
22 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- General practice incentives: a review of the international literature.The British journal of general practice : the journal of the Royal College of General Practitioners · 2026Pooled it
- The VBHC big picture: an umbrella review.BMC health services research · 2025Pooled it
- The lack of creative destruction in healthcare systems makes innovation a cost driver.Wiener klinische Wochenschrift · 2026Article
- Service-Level Utilization in Risk-Based Contracts and a Benchmarking Approach for Fee-Schedule Reforms.JAMA health forum · 2026Article
- From Evidence to Value: Integrating Evidence-Based Medicine, Patient Safety, Quality Improvement, Learning Health Systems, and Value-Based Healthcare.Journal of evaluation in clinical practice · 2026Review
- Remote Patient Monitoring Adoption for Hypertension Management Among Medicare Beneficiaries.JAMA network open · 2026Observational
- Managing urinary incontinence: evaluating the role of practice facilitators in enhancing quality improvement and digital integration in primary care.Implementation science communications · 2026Article
- Paying for hospital care in seven central and Eastern European countries - a comparative analysis.Health economics review · 2026Article
- Conceptual Model for the Integration of Marketing Strategies and Biomedical Innovation in Patient-Centered Care: Mixed Methods Study.JMIR biomedical engineering · 2026Article
- Health system governance and pharmaceutical policy in Australia and Qatar: a comparative overview of access, reform, and equity.Journal of pharmaceutical policy and practice · 2026Article
- Risk Governance of Payment Exceptions Under China's DRG/DIP Reform: A Structured Policy-Text Analysis of Special Case Negotiation Rules.Risk management and healthcare policy · 2026Article
- Most-Favored-Nation Benchmarking Versus Value-Based Contracting: Institutional Fit of Pharmaceutical Pricing Tools in the United States, Canada, and the United Kingdom.Health services insights · 2026Article
- Assessing preventive dental care in Italy: insights from a KAP survey.BMC oral health · 2025Article
- The Value of Radiation Therapists in Online Adaptive Radiotherapy.Journal of medical radiation sciences · 2025Article
- The effect of hospital budgeting system on physician-executives' budget cognitive consciousness and medical decision making.Cost effectiveness and resource allocation : C/E · 2025Article
- Design, implementation and evaluation of value-based payment models: a Delphi study.BMC health services research · 2025Article
- Substantial Increase in the Costs of Antineoplastic Agents in the USA from 2010 to 2021.ClinicoEconomics and outcomes research : CEOR · 2025Article
- Bibliometric Analysis of Outpatient Hip and Knee Arthroplasty Research Evolution.The archives of bone and joint surgery · 2025Article
- From endoscopy to surgery: a translational perspective on early esophageal cancer management.Frontiers in medicine · 2025Article
- Is Economic Evaluation and Care Commissioning Focused on Achieving the Same Outcomes? Resource-Allocation Considerations and Challenges Using England as a Case Study.Applied health economics and health policy · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
introductionValue-based healthcare has potential for cost control and quality improvement. To assess this, we review the evidence on the impact of value-based payment (VBP) models in the context of networks of care (NOC) and transmural care.
methodsWe used the PRISMA guidelines for this systematic literature review. We searched eight databases in July 2021. Subsequently, we conducted title and abstract and full-text screenings, and extracted information in an extraction matrix. Based on this, we assessed the evidence on the effects of VBP models on clinical outcomes, patient-reported outcomes/experiences, organization-related outcomes/experiences, and costs. Additionally, we reviewed the facilitating and inhibiting factors per VBP model.
findingsAmong articles studying shared savings and pay-for-performance models, most outline positive effects on both clinical and cost outcomes, such as preventable hospitalizations and total expenditures, respectively. Most studies show no change in patient satisfaction and access to care when adopting VBP models. Providers' opinions towards the models are frequently negative. Transparency and communication among involved stakeholders are found to be key facilitating factors, transversal to all models. Additionally, a lack of trust is an inhibitor found in all VBP models, together with inadequate targets and insufficient incentives. In bundled payment and pay-for-performance models, complexity in the structure of the program and lack of experience in implementing required mechanisms are key inhibitors.
conclusionsThe overall positive effect on clinical and cost outcomes validates the success of VBP models. The mostly negative effects on organization-reported outcomes/experiences are corroborated by findings regarding providers' lack of awareness, trust, and engagement with the model. This may be justified by their exclusion from the design of the models, decreasing their sense of ownership and, therefore, motivation. Incentives, targets, benchmarks, and quality measures, if adequately designed, seem to be important facilitators, and if lacking or inadequate, they are key inhibitors. These are prominent facilitators and inhibitors for P4P and shared savings models but not as prominent for bundled payments. The complexity of the scheme and lack of experience are prominent inhibitors in all VBP models, since all require changes in several areas, such as behavioral, process, and infrastructure.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.